VANI vs. RCEL, LUNG, ELMD, INGN, ZYXI, LAKE, DRTS, OBIO, NVRO, and BWAY
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include AVITA Medical (RCEL), Pulmonx (LUNG), Electromed (ELMD), Inogen (INGN), Zynex (ZYXI), Lakeland Industries (LAKE), Alpha Tau Medical (DRTS), Orchestra BioMed (OBIO), Nevro (NVRO), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry.
Vivani Medical vs.
AVITA Medical (NASDAQ:RCEL) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.
AVITA Medical presently has a consensus target price of $17.25, indicating a potential upside of 76.92%. Vivani Medical has a consensus target price of $3.00, indicating a potential upside of 160.87%. Given Vivani Medical's stronger consensus rating and higher probable upside, analysts clearly believe Vivani Medical is more favorable than AVITA Medical.
Vivani Medical has lower revenue, but higher earnings than AVITA Medical. AVITA Medical is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.
AVITA Medical has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 3.22, meaning that its share price is 222% more volatile than the S&P 500.
In the previous week, AVITA Medical had 12 more articles in the media than Vivani Medical. MarketBeat recorded 12 mentions for AVITA Medical and 0 mentions for Vivani Medical. AVITA Medical's average media sentiment score of 0.46 beat Vivani Medical's score of 0.44 indicating that AVITA Medical is being referred to more favorably in the media.
27.7% of AVITA Medical shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 1.8% of AVITA Medical shares are held by company insiders. Comparatively, 44.3% of Vivani Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
AVITA Medical received 78 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 69.57% of users gave AVITA Medical an outperform vote.
Vivani Medical has a net margin of 0.00% compared to AVITA Medical's net margin of -96.26%. Vivani Medical's return on equity of -102.42% beat AVITA Medical's return on equity.
Summary
Vivani Medical beats AVITA Medical on 10 of the 16 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
This page (NASDAQ:VANI) was last updated on 2/22/2025 by MarketBeat.com Staff
